Fulvestrant EVER Pharma

Medicinal product

(Invented) name

Fulvestrant EVER Pharma

Active substance (s)

Fulvestrantas

Strength

250 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02BA03, Fulvestrant

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-07-23

Date of renewal

Documents

2723_Fulvestrant EVER Pharma 250mg_inj_tirp_svirkste_PL_2025-07-23.docx

2723_Fulvestrant EVER Pharma 250mg_inj_tirp_svirkste_PZ_2025-07-23.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Viename užpildytame švirkšte yra:	5 ml
Fulvestrantas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118180	104288	1104288	užpildytas švirkštas	užpildytas švirkštas, 5 ml ir injekcinė adata N2		Receptinis	LT/L/25/2723/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-07-23	Registruotas